The American economy while battered, shaken, and plagued by staggering debt from wasteful government spending continues to remain relatively safe to many in the business world. Conventional American medicine boasts amazing technology and innovation but it remains unlike any other segment of the economy as most Americans would currently agree it’s a broken system.
Tag: Big Pharma
The Little Purple Pill Problem
Forbes magazine calls it “a parable of what’s wrong with health care [costs].” We think that the popular drug Nexium is a scandal for a different reason – what it does to your digestion.
Children Are Being Exploited to Extend Pharmaceutical Patents
Want to protect your kids from high cholesterol? Just give ’em drugs—like the new, chewable form of Lipitor. Yes, chewable. Like candy. A new Action Alert asks Congress to repeal a really rotten law that encourages this.
Cancer, Chemo, and Crony Capitalism
When Medicare reduced reimbursements for oncologists in 2003, some physicians started giving their patients more expensive chemotherapy and other cancer treatments—in return for kickbacks from the pharmaceutical companies, a new study has found.
Alert: Protect Your Right To Natural and Bio-available Vitamin B-6!
Human beings cannot live without vitamin B-6. The FDA recently gave one natural form of this critical vitamin to a drug company for its exclusive use. Another drug company wants the most important natural form as well, the one that our bodies cannot do without. Please help stop this outrageous vitamin grab.
FDA Ignored Urgent Warnings
The Food and Drug Administration has disregarded government experts sounding the alarm about routine exposure to medical radiation, including the powerful CT scans used to screen for colon cancer. This is yet another example of why fundamental FDA reform remains so important.
Just How Broken is the FDA?
The reexamination of a knee device and a campaign to extend the patent of a blood-thinning medication underscore the need for FDA reform.
Expensive, Dangerous
Evidence mounts that many of the procedures that constitute the current “standard of care” fail to promote health, are unnecessary and may put patients at greater risk. These risks increase with a standardized, one-size-fits-all form of monopoly medicine.
Make Your Voice Heard on the Healthcare Bills!
After months of negotiating and back-door dealing, Congress is set to pass industry-friendly healthcare legislation at the expense of consumer choice. Please contact your elected representative today and tell him or her to vote NO on the healthcare bill!
FDA Memo Blasts Diabetes Medicine Avandia
Sens. Charles Grassley, I-Iowa, and Max Baucus, D-Mont., have released an October 2008 memo written by FDA drug-safety reviewers Drs. David Graham and Kate Gelperin. The memo concludes that Avandia poses serious risks exceeding those of Actos, a competing drug.